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Frasier syndrome in 17-year-old girl 
– case report 
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 Abstract
The authors present a case of Frasier syndrome in a 17-year-old girl with nephrotic syndrome and male 
pseudohermaphroditism. Due to the existing risk of developing tumors in dysgenetic gonads, the patient was 
admitted to the clinic for prophylactic gonadectomy. The operation was then postponed as a result of rapid 
progression to end-stage renal failure, and the patient was placed on hemodialysis. During subsequent laparoscopy, 
both ovaries and dysgenetic gonads were resected. Histopathological examination revealed the presence of both 
seminal ducts and epididymis. Early prophylactic resection of dysgenetic gonads, such as was undertaken in this 
patient, is indicated in children with Frasier syndrome to  prevent the development of germ cell tumors.
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 Streszczenie
Autorzy prezentują przypadek 17-letniej dziewczynki z zespołem nerczycowym i obojnactwem rzekomym męskim. 
Z powodu ryzyka nowotworu wywodzącego się z dysgenetycznych gonad dziewczynka została przyjęta do Kliniki 
Chirurgii Dziecięcej do profilaktycznej gonadektomii. Planowany zabieg został odroczony z powodu pogorszenia 
funkcji nerek aż do ich schyłkowej niewydolności. Po wdrożeniu leczenia nerkozastępczego i wyrównaniu parametrów 
gospodarki azotowej wykonano laparoskopową gonadektomię obustronną z usunięciem obu jajowodów. W badaniu 
histopatologicznym w gonadach stwierdzono struktury najądrza i przewodów nasiennych. Wczesne profilaktyczne 
usunięcie dysgenetycznych gonad jest wskazane u dzieci z zespołem Frasiera w celu zapobiegania powstania 
guza wywodzącego się z komórek germinalnych.
 Słowa kluczowe: zespół Frasiera / obojnactwo rzekome / zaburzenia różnicowania 
       płci / niewydolność nerek / zespół nerczycowy /  
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Frasier	syndrome	was	first	described	by	Frasier	et	al.	in	1964	
as	an	association	between	glomerulosclerosis,	male	to	female	sex	
reversal,	and	dysgenetic	gonads	in	a	pair	of	monozygotic	twins	
[1].	Further	reports	have	described	this	syndrome	in	association	
with	 the	 risk	 of	 dysgenetic	 gonads,	 as	 a	 predisposing	 factor	
for	 gonadoblastoma	 [2,	 3,	 4,	 5].	 Polymerase	 chain	 reaction	
amplification	testing	can	confirm	such	a	diagnosis,	generally	by	
demonstrating	mutation	in	the	WT1	gene.	Mutations	of	the	WT1	
gene	are	also	present		in	a	minority	of	patients	with	Wilms’	tumor,	
as	well	as		children	with	Denys-Drash	and/or	WAGR	syndromes.	
WT1	gene	acts	as	a	tumor	suppressor	gene	and	has	four	different	
isoforms.	 Patients	 with	 Frasier	 syndrome	 display	mutations	 in	
intron	9	[2,	6,	7,	8].
Case report
A	 17-year	 old	 girl	 was	 referred	 to	 the	 gynecological	
outpatient	 clinic,	 because	 of	 primary	 amenorrhea.	 The	 girl’s	
physical	 examination	 was	 consistent	 with	 Tanner	 3	 stage	 of	
development.	Her	weight	was	57kg,	height	–	167cm	(BMI:20.4).	
Prior	medical	history	made	mention	of	the	fact,	that	at	the	age	of	
7,	she	developed	hypertension	because	of	nephrotic	syndrome	and	
segmental	glomerulosclerosis.	As	a	result	of	the	aforementioned,	
the	patient	was	prescribed	Encortone,	Amlodipinum,	Enalapril,	
Furosemidum.	Ultimately,	 she	was	admitted	 to	 the	Department	
of	 Pediatric	 Surgery	 at	 the	 Children’s	 University	 Hospital	 in	
Bialystok,	 for	 further	 investigation	 concerning	 her	 lack	 of	
menses.	
Thyroid	 function	 was	 normal.	 In	 trans-abdominal	 pelvic	
ultrasound,	neither	the	uterus	nor	the	expected	appendages	were	
identified.	Vaginoscopy	 showed	 a	 small	 vagina,	with	 a	 lack	 of	
a	visible	cervix.	Chromosomal	analysis	showed	SRY	sequences	
consistent	with	XY	 genotype.	The	DNA	 analysis	 attested	 to	 a	
mutation	in	the	WT1	gene,	consistent	with	Frasier	syndrome.	The	
cytohormone	vaginal	smear	revealed	features	of	active	estrogen	
function	The	patient	was	subsequently	subject	to	an		oral	hormone	
replacement,	in	the	form	of	an		estrogen-progesterone	pill	(Cyclo-
Progynova).	 Following	 the	 introduction	 of	 such	 treatment,	 the	
girl	began	to	menstruate	regularly.
The	 diagnosis	 of	 Frasier	 syndrome	 may	 be	 based	 on	 the	
presence	 of	 specific	 mutation	 in	 the	 WT1	 gene,	 nephrotic	
syndrome	 associated	with	 diffuse	mesangial	 sclerosis	 that	 lead	
to	chronic	renal	failure,	and	a	46XY	karyotype	in	a	phenotypic	
female.	 Due	 to	 the	 risk	 of	 developing	 tumors	 in	 dysgenetic	
gonads,	 a	 laparoscopic	 evaluation	 of	 the	 abdomen	 with	
subsequent	gonadectomy	was	planned.	Laboratory	tests	showed	
elevated	levels	of	serum	urea	(122mg/dl)	and	creatinine	(6,96mg/
dl).	 The	 laparoscopy	 was	 then	 postponed,	 and	 the	 patient	
underwent	 hemodialysis.	 Once	 serum	 levels	 of	 both	 urea	 and	
creatinine	 diminished,	 the	 laparoscopy	 was	 undertaken.	 Prior	
to	 	 the	operation,	 the	colon	was	emptied	with	an	enema,	and	a	
Foley	catheter	was	inserted.	The	operation	was	performed	under	
general	 anesthesia	 with	 endotracheal	 intubation,	 in	 the	 supine	
position.	Open	 access	was	 attained	 through	 the	 use	 of	 a	 blunt	
trocar,	 placed	 	 at	 the	 rim	 of	 the	 umbilicus.	 Two	 other	 trocars	
were	 introduced	 under	 visual	 guidance,	 into	 the	 right	 and	 left	
iliac	fossa	respectively.	Pressure	of	12	mmHg	of	carbon	dioxide	
was	used.	Three	cannulas	were	sufficient	for	this	procedure,	an	
umbilical	 one	 for	 the	 telescope,	 and	 2	 other	 ones	 (in	 the	 right	
and	left	lower	quadrants)	for	instrumentation.	In	the	right	lower	
quadrant,	 we	 used	 a	 10mm	 cannula	 for	 both	 instrumentation	
and	removal	of	 the	specimen,	while	 in	 the	 left	 lower	quadrant;	
a	 5mm	 cannula	 was	 inserted.	 During	 the	 operation,	 a	 small	
uterus	and	two	obliterated	Fallopian	tubes	were	visualized.	Both	
gonads	spread	as	a	strand	along	the	Fallopian	tubes.	The	ovaries	
and	the	dysgenetic	gonads	were	both	resected.	Hemostasis	was	
reached	 with	 electrocoagulation	 and	 staples.	 Histopathological	
examination	 then	 revealed	seminal	ducts	and	epididymis	along	
the	obliterated	Fallopian	tubes.	The	patient	was	discharged	from	
the	 hospital	 on	 the	 second	 day	 post-hoc.	 Diffuse	 mesangial	
sclerosis	 is	 a	 rare	 cause	 of	 end-stage	 renal	 failure.	 It	 usually	
presents	 as	 nephrotic	 syndrome	with	 rapid	progression	 to	 end-
stage	renal	failure	[6].	In	children	with	early	onset	of	proteinuria,	
rapid	 deterioration	 of	 renal	 function	 and	 female	 phenotype	 or	
ambiguous	genitalia,	both	a	karyotype	and	a	WT1	gene	analysis	
ought	to	be	performed	[3,	6,	7,	8].	It	is	of	utmost	importance	to	
correctly	differentiate	all	of	the	syndromes	associated	with	WT1	
mutations,	 as	 each	one	predisposes	 towards	 a	different	 type	of	
tumor	 [6].	The	 inclusion	 of	 nephropathy	within	 the	 context	 of	
Frasier	syndrome	remains	a	poor	prognostic	factor,	although	the	
mortality	rate	has	decreased	significantly	in	the	last	decade.	Vast	
advances	in	hemodialysis	and	living-donor	transplantations	have	
both	allowed	for	an	improved	quality	of	life	and	a	prolonged	life-
span.	[4,	9].
Dysgenetic	 gonads	 can	 be	 unilaterally	 or	 bilaterally	
undescended.	Persistent	Mullerian	structures	may	link	the	gonads	
together,	causing	one	gonad	to	migrate	to	the	contralateral	side	[1,	
2,	3,	10].	In	patients	with	dysgerminoma,	computed	tomography	
or	 magnetic	 resonance	 imaging	 is	 indicated.	 Tumor	 staging	
includes	 examination	 of	 the	 abdominal	 cavity,	 diaphragm,	
omentum,	paracolic	gutters,	paraaortic,	and	pelvic	lymph	nodes.	
Serum	 alpha-fetoprotein	 and	 human	 chorionic	 gonadotropin	
levels	can	serve	as	markers	of	unresected	or?	recurrent	disease	[3,	
6,	9].	Sometimes	patients	do	not	live	long	enough	to	develop	the	
cancers	associated	with	these	syndromes,	and	this	may	account	
for	the	missed	diagnosis	in	patients	with	the	female	phenotype.	It	
is	important	to	determine	the	presence	of	a	genetic	alteration	in	
 
Picture 1. Small uterus with obliterated Fallopian tubes and dysgenetic gonads. 
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order	to	offer	familial	genetic	counseling	[9]	further	knowledge	
within	 the	 field	 may	 also	 be	 used	 by	 the	 patients	 themselves,	
possibly	as	part	of	a	biopsychosocial	model	of	adjustment	when	
it	comes	to	their	daily	dealings	with	the	disease.	
Conclusion
Early	prophylactic	resection	of	dysgenetic	gonads	is	indicated	
in	children	with	Frasier	syndrome	to	prevent	the	development	of	
germ	cell	tumors.	It	may	also	serve	a	potential	future	role	in	the	
development	and/or	 improvement	of	genetic	and	psychological	
familial	counseling.
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